DK0464124T3 - Peptid, immunogen sammensætning og vaccine eller medicinsk præparat, fremgangsmåde til immunisering af et pattedyr mod LHRH og fremgangsmåde til forbedring af kødkvaliteten hos grise - Google Patents

Peptid, immunogen sammensætning og vaccine eller medicinsk præparat, fremgangsmåde til immunisering af et pattedyr mod LHRH og fremgangsmåde til forbedring af kødkvaliteten hos grise

Info

Publication number
DK0464124T3
DK0464124T3 DK90905697.0T DK90905697T DK0464124T3 DK 0464124 T3 DK0464124 T3 DK 0464124T3 DK 90905697 T DK90905697 T DK 90905697T DK 0464124 T3 DK0464124 T3 DK 0464124T3
Authority
DK
Denmark
Prior art keywords
pigs
peptide
immunizing
vaccine
improving
Prior art date
Application number
DK90905697.0T
Other languages
English (en)
Inventor
Robert Hans Meloen
Cornelis Johannes G Wensing
Original Assignee
Stichting Centr Diergeneeskund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Centr Diergeneeskund filed Critical Stichting Centr Diergeneeskund
Application granted granted Critical
Publication of DK0464124T3 publication Critical patent/DK0464124T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
DK90905697.0T 1989-03-23 1990-03-22 Peptid, immunogen sammensætning og vaccine eller medicinsk præparat, fremgangsmåde til immunisering af et pattedyr mod LHRH og fremgangsmåde til forbedring af kødkvaliteten hos grise DK0464124T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8900726A NL8900726A (nl) 1989-03-23 1989-03-23 Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.

Publications (1)

Publication Number Publication Date
DK0464124T3 true DK0464124T3 (da) 1994-05-02

Family

ID=19854349

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90905697.0T DK0464124T3 (da) 1989-03-23 1990-03-22 Peptid, immunogen sammensætning og vaccine eller medicinsk præparat, fremgangsmåde til immunisering af et pattedyr mod LHRH og fremgangsmåde til forbedring af kødkvaliteten hos grise

Country Status (11)

Country Link
EP (1) EP0464124B1 (da)
JP (1) JP3098771B2 (da)
AT (1) ATE103297T1 (da)
CA (1) CA2049325C (da)
DE (1) DE69007616T2 (da)
DK (1) DK0464124T3 (da)
ES (1) ES2050435T3 (da)
HU (1) HU214742B (da)
NL (1) NL8900726A (da)
RU (1) RU2078770C1 (da)
WO (1) WO1990011298A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
US5171835A (en) * 1988-10-21 1992-12-15 The Administrators Of The Tulane Educational Fund LHRH antagonists
US5324512A (en) * 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
CA2081660C (en) * 1991-03-01 2001-05-01 Raymond Dufour Method for improving the organoleptic qualities of the meat from uncastrated male domestic animals and vaccine set for use in this method
US5837268A (en) * 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
US5723129A (en) * 1991-10-16 1998-03-03 University Of Saskatchewan GnRH-leukotoxin chimeras
ZA934199B (en) * 1992-06-18 1994-01-10 Akzo Nv Carrier system against gnrh
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
EP0832107B1 (en) * 1995-06-07 2001-09-05 DLO Instituut voor Dierhouderij en Diergezondheid An improved peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone lhrh, and analogs of the lhrh tandem repeat peptide and their use as vaccine
USRE39048E1 (en) 1995-06-07 2006-03-28 Pepscan Systems B.V. Peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
US6761890B1 (en) 1995-06-07 2004-07-13 Pepscan Systems B.V. Peptide, immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
EP0912195B1 (en) * 1996-06-25 2009-01-21 Pepscan Systems B.V. Vaccine comprising antigens bound to carriers through labile bonds
AUPO776897A0 (en) 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
EP1098661A2 (en) * 1998-06-04 2001-05-16 Metamorphix, Inc. Gnrh vaccines for suppressing reproductive behavior in animals
US6838553B1 (en) * 1999-10-05 2005-01-04 Academia Sinica Peptide repeat immunogens
AU2004232314B2 (en) 2003-04-22 2007-11-22 Ipsen Pharma S.A.S. Peptide vectors
CU23739A1 (es) 2008-09-30 2011-12-28 Ct Ingenieria Genetica Biotech Composición farmacéutica utilizando combinaciones de variantes de la hormona liberadora de las gonadotropinas (gnrh) como inmunógeno
RU2521652C2 (ru) * 2010-12-27 2014-07-10 Общество с ограниченной ответственностью "Научно-внедренческое предприятие "Астрафарм" РЕКОМБИНАНТНАЯ ДНК, КОДИРУЮЩАЯ ГИБРИДНЫЙ ВАКЦИННЫЙ БЕЛОК GHbc ДЛЯ РЕГУЛЯЦИИ ПОЛОВОЙ ФУНКЦИИ У ЖИВОТНЫХ, СОСТОЯЩИЙ ИЗ НУКЛЕОКАПСИДНОГО БЕЛКА ВИРУСА ГЕПАТИТА В ЧЕЛОВЕКА СЛИТОГО С ГОНАДОЛИБЕРИНОМ
RU2529959C1 (ru) * 2013-10-09 2014-10-10 Общество с ограниченной ответственностью ООО "Нанолек" Иммунологический адъювант на основе наночастиц для вакцин против высокопатогенных штаммов вируса гриппа
WO2016014071A1 (en) * 2014-07-25 2016-01-28 United Biomedical, Inc Immunogenic lhrh composition and use thereof in pigs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608251A (en) * 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
WO1988005308A1 (en) * 1987-01-14 1988-07-28 Commonwealth Scientific And Industrial Research Or Anti reproductive hormone

Also Published As

Publication number Publication date
DE69007616D1 (de) 1994-04-28
HU902930D0 (en) 1991-12-30
CA2049325C (en) 2000-07-25
ATE103297T1 (de) 1994-04-15
EP0464124B1 (en) 1994-03-23
JPH04504256A (ja) 1992-07-30
NL8900726A (nl) 1990-10-16
RU2078770C1 (ru) 1997-05-10
JP3098771B2 (ja) 2000-10-16
HU214742B (hu) 1998-10-28
ES2050435T3 (es) 1994-05-16
DE69007616T2 (de) 1994-06-30
HUT62916A (en) 1993-06-28
WO1990011298A1 (en) 1990-10-04
EP0464124A1 (en) 1992-01-08
CA2049325A1 (en) 1990-09-24

Similar Documents

Publication Publication Date Title
DK0464124T3 (da) Peptid, immunogen sammensætning og vaccine eller medicinsk præparat, fremgangsmåde til immunisering af et pattedyr mod LHRH og fremgangsmåde til forbedring af kødkvaliteten hos grise
UA40597C2 (uk) Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
ATE127345T1 (de) Stressproteine und verwendungen dafür.
BR9814473A (pt) Imunógenos anti-retrovirais, preparação e uso
CY2612B2 (en) Compounds for immunotherapy and diagnosis of tuberculosis
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
ATE411043T1 (de) Verfahren von dna-impfung
GEP20022695B (en) Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence and Uses Thereof
CO5280094A1 (es) Un analogo de a o app y una composicion inmunogenica que comprende dicho analogo
AR245778A1 (es) Secuencia de nucleotido que codifica una proteina de membrana exterior de neisseria meningitis y uso de dicha proteina en preparaciones de vacuna
IL125590A (en) Peptide immunogens, process for their preparation and use thereof as vaccines against allergies
IL276661B2 (en) Immunogenic preparation containing staphylococcal antigens
DK0896583T3 (da) Anvendelse af peptidfragmenter fra OspC til diagnostiske metoder
ZA936970B (en) Anti-feline immunodeficiency virus (FIV) vaccines
BR9812240A (pt) Proteìna g alterada ou polipeptìdeo do rsv, uso da mesma, molécula de ácido nucleico codificando uma proteìna g alterada ou um polipeptìdeo do rsv, construção do ácido nucleico, célula hospedeira recombinante, processos de produção de uma proteìna g alterada ou polipeptìdeo do rsv composição imunogênica, de indução de uma resposta imune em um vertebrado, de inibir a indução do aumento da doença após a vacinação e subsequente infecção de um vertebrado com o rsv e de imunização de um vertebrado contra o rsv, composição de vacina, vacina, e, composição imunogênica
HUP0001431A3 (en) An improved peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone lhrh , and analogs of the lhrh tandem repeat peptide and their use as vaccine
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
DK0833903T3 (da) Multivalent vaccine mod bovint coronavirus og fremgangsmåde til behandling af infektioner forårsaget af bovint coronavirus
ES2079851T3 (es) Uso de il-4 para mejorar la respuesta inmunitaria frente a inmunogenos en vacunas.
CA2516661A1 (en) M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever
RU98112608A (ru) Иммуногенная композиция [на основе] tlp
FR2646776B1 (fr) Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
NO995290L (no) Anti-helicobacter-vaksineblanding for anvendelse av den subdiafragmatiske systemiske ruten og kombinert mukosal/parenteral immuniseringsmetode
RU2003110420A (ru) Дифференцирование gnrh-i и gnrh-ii
BRPI0009746C1 (pt) molécula de veículo contendo plasmídeo pg-pviii compreendendo uma seqúência que codifica uma parte de uma glicoproteína de lissavírus contendo pelo menos o sítio iii da glicoproteína de lissavírus mas não contendo o sítio ii, e, composição imunogênica